| Patent | Date |
|---|
Combination Therapy With A Bet Inhibitor And A Proteasome Inhibitor
App 20210023099 - Demario; Mark D. ; et al. | 2021-01-28 |
Combination Therapy With A Bet Inhibitor And A Bcl-2 Inhibitor
App 20200237779 - DEMARIO; Mark D. ; et al. | 2020-07-30 |
Combination Therapy With A Bet Inhibitor, A Bcl-2 Inhibitor And An Anti-cd20 Antibody
App 20200237905 - DEMARIO; Mark D. ; et al. | 2020-07-30 |
Anti-tpbg Antibodies And Methods Of Use
App 20200108154 - DENGL; Stefan ; et al. | 2020-04-09 |
Anti-TPBG antibodies and methods of use
Grant 10,434,184 - Dengl , et al. O | 2019-10-08 |
Anti-HER3 antibodies and uses thereof
Grant 10,196,456 - Bossenmaier , et al. Fe | 2019-02-05 |
Anti-tpbg Antibodies And Methods Of Use
App 20180311371 - DENGL; Stefan ; et al. | 2018-11-01 |
Tumor Therapy With An Anti-vegf Antibody
App 20180251536 - Friess; Thomas ; et al. | 2018-09-06 |
Combination Therapy Of Bispecific Antibodies Specific For Fap And Dr5 And Chemotherapeutic Agents
App 20180064808 - Friess; Thomas ; et al. | 2018-03-08 |
Tumor Therapy With An Antibody For Vascular Endothelial Growth Factor And An Antibody For Human Epithelial Growth Factor Receptor Type 2
App 20170239353 - Friess; Thomas ; et al. | 2017-08-24 |
Anti-her3 Antibodies And Uses Thereof
App 20170174784 - Bossenmaier; Birgit ; et al. | 2017-06-22 |
Anti-HER3 antibodies and uses thereof
Grant 9,611,331 - Bossenmaier , et al. April 4, 2 | 2017-04-04 |
Combination Therapy Of Anti-her3 Antibodies
App 20160159912 - Bauss; Frieder ; et al. | 2016-06-09 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxity (adcc)
App 20160000911 - DUMONTET; CHARLES ; et al. | 2016-01-07 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Proteasome Inhibitor
App 20160000912 - FERTIG; GEORG ; et al. | 2016-01-07 |
Combination therapy of anti-HER3 antibodies
Grant 9,180,185 - Bauss , et al. November 10, 2 | 2015-11-10 |
Tumor Therapy with an Antibody for Vascular Endothelial Growth Factor and an Antibody for Human Epithelial Growth Factor Receptor Type 2
App 20150283238 - Friess; Thomas ; et al. | 2015-10-08 |
Tumor Therapy With An Anti-vegf Antibody
App 20150239969 - Friess; Thomas ; et al. | 2015-08-27 |
Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
Grant 9,090,700 - Friess , et al. July 28, 2 | 2015-07-28 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With An Anti-bcl-2 Active Agent
App 20150056186 - FRIESS; THOMAS ; et al. | 2015-02-26 |
Anti-her3 Antibodies And Uses Thereof
App 20140377273 - Bossenmaier; Birgit ; et al. | 2014-12-25 |
Anti-her3 Antibodies And Uses Thereof
App 20140377272 - Bossenmaier; Birgit ; et al. | 2014-12-25 |
Anti-HER3 antibodies and uses thereof
Grant 8,859,737 - Bossenmaier , et al. October 14, 2 | 2014-10-14 |
Combination Therapy With Type I And Type Ii Anti-cd20 Antibodies
App 20140294807 - FRIESS; THOMAS ; et al. | 2014-10-02 |
Combination Therapy Of Anti-her3 Antibodies
App 20140227255 - Bauss; Frieder ; et al. | 2014-08-14 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxity (adcc)
App 20140065134 - DUMONTET; CHARLES ; et al. | 2014-03-06 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With An Anti-bcl-2 Active Agent
App 20140004104 - FRIESS; THOMAS ; et al. | 2014-01-02 |
Combination Therapy With Type I And Type Ii Anti-cd20 Antibodies
App 20130195846 - FRIESS; THOMAS ; et al. | 2013-08-01 |
Tumor Therapy With An Anti-vegf Antibody
App 20130183292 - Friess; Thomas ; et al. | 2013-07-18 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxicity (adcc)
App 20120301459 - Dumontet; Charles ; et al. | 2012-11-29 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With An Anti-bcl-2 Active Agent
App 20120276085 - Friess; Thomas ; et al. | 2012-11-01 |
Combination therapy of a type II anti-CD20 antibody with a proteasome inhibitor
App 20120219549 - Fertig; Georg ; et al. | 2012-08-30 |
Combination Therapy With Type I And Type Ii Anti-cd20 Antibodies
App 20120134990 - Friess; Thomas ; et al. | 2012-05-31 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With An Anti-bcl-2 Active Agent
App 20110287006 - Friess; Thomas ; et al. | 2011-11-24 |
Combination Therapy With Type I And Type Ii Anti-cd20 Antibodies
App 20110243931 - Friess; Thomas ; et al. | 2011-10-06 |
Tumor Therapy With An Anti-vegf Antibody
App 20110223159 - Friess; Thomas ; et al. | 2011-09-15 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With A Proteasome Inhibitor
App 20110200598 - Fertig; Georg ; et al. | 2011-08-18 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxicity (adcc)
App 20110177067 - Dumontet; Charles ; et al. | 2011-07-21 |
Anti-her3 Antibodies And Uses Thereof
App 20110171222 - Bossenmaier; Birgit ; et al. | 2011-07-14 |
Combination Therapy of a Type II Anti-CD20 Antibody with an Anti-BCL-2 Active Agent
App 20110086025 - Friess; Thomas ; et al. | 2011-04-14 |
Tumor Therapy With An Antibody For Vascular Endothelial Growth Factor And An Antibody For Human Epithelial Growth Factor Receptor Type 2
App 20110064736 - Friess; Thomas ; et al. | 2011-03-17 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxicity (adcc)
App 20100310581 - Dumontet; Charles ; et al. | 2010-12-09 |
Tumor Therapy With An Anti-vegf Antibody
App 20100285010 - Friess; Thomas ; et al. | 2010-11-11 |
TREATMENT WITH A HUMANIZED ANTI-EGFR IgG1 ANTIBODY AND IRINOTECAN
App 20100247533 - Friess; Thomas ; et al. | 2010-09-30 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With Increased Antibody Dependent Cellular Cytotoxicity (adcc)
App 20090246197 - DUMONTET; CHARLES ; et al. | 2009-10-01 |
Combination Therapy Of Type Ii Anti-cd20 Antibody With A Proteasome Inhibitor
App 20090110688 - FERTIG; GEORG ; et al. | 2009-04-30 |
Combination Therapy Of A Type Ii Anti-cd20 Antibody With An Anti-bcl-2 Active Agent
App 20090098118 - Friess; Thomas ; et al. | 2009-04-16 |
Combination Therapy With Type I And Type Ii Anti-cd20 Antibodies
App 20090060913 - Friess; Thomas ; et al. | 2009-03-05 |
Ether derivatives
Grant 7,432,291 - Bossenmaier , et al. October 7, 2 | 2008-10-07 |
Phenylpyridine derivatives
Grant 7,429,605 - Bossenmaier , et al. September 30, 2 | 2008-09-30 |
Oxidized thioether derivatives
Grant 7,405,231 - Bossenmaier , et al. July 29, 2 | 2008-07-29 |
Tumor Therapy With A Combination Of Anti-her2 Antibodies
App 20080102069 - Friess; Thomas ; et al. | 2008-05-01 |
Indole derivatives
Grant 7,342,030 - Friess , et al. March 11, 2 | 2008-03-11 |
Tumor Therapy With An Anti-vegf Antibody
App 20080050385 - Friess; Thomas ; et al. | 2008-02-28 |
Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2
App 20070224203 - Friess; Thomas ; et al. | 2007-09-27 |
Oxazole derivatives
Grant 7,205,325 - Bossenmaier , et al. April 17, 2 | 2007-04-17 |
Phenylpyridine derivatives
App 20070032530 - Bossenmaier; Birgit ; et al. | 2007-02-08 |
Benzylether derivatives
Grant 7,163,953 - Bossenmaier , et al. January 16, 2 | 2007-01-16 |
Indole derivatives
App 20060063812 - Friess; Thomas ; et al. | 2006-03-23 |
Thioether derivatives
Grant 7,005,526 - Bossenmaier , et al. February 28, 2 | 2006-02-28 |
Novel benzylether derivatives
App 20050267178 - Bossenmaier, Birgit ; et al. | 2005-12-01 |
Novel Thioether Derivatives
App 20050267179 - Bossenmaier, Birgit ; et al. | 2005-12-01 |
Novel ether derivatives
App 20050209290 - Bossenmaier, Birgit ; et al. | 2005-09-22 |
Novel oxidized thioether derivatives
App 20050203064 - Bossenmaier, Birgit ; et al. | 2005-09-15 |
Oxazole derivatives
App 20040209933 - Bossenmaier, Birgit ; et al. | 2004-10-21 |
Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof
App 20040132739 - Friess, Thomas ; et al. | 2004-07-08 |
| 